Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

1.

Recent Infection, Sexually Transmitted Infections and Transmission Clusters Frequently Observed Among Persons Newly-Diagnosed with HIV in San Francisco.

Truong HH, Pipkin S, O'Keefe KJ, Louie B, Liegler T, McFarland W, Grant RM, Bernstein K, Scheer S.

J Acquir Immune Defic Syndr. 2015 May 11. [Epub ahead of print]

PMID:
25967271
2.

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial: DXA Results from iPrEx.

Mulligan K, Glidden DV, Anderson PL, Liu A, McMahan V, Gonzales P, Ramirez-Cardich ME, Namwongprom S, Chodacki P, de Mendonca LM, Wang F, Lama JR, Chariyalertsak S, Guanira JV, Buchbinder S, Bekker LG, Schechter M, Veloso VG, Grant RM; iPrEx Study Team.

Clin Infect Dis. 2015 Apr 23. pii: civ324. [Epub ahead of print]

PMID:
25908682
3.

Concentrations of TFV-DP/FTC-TP in dried blood spots and TFV/FTC in hair are strongly correlated in iPrEx OLE: Implications for PrEP adherence monitoring.

Gandhi M, Glidden DV, Liu A, Anderson PL, Horng H, Defechereuz P, Guanira JV, Chariyalertsak S, Bekker LG, Grant RM; iPrEX study team.

J Infect Dis. 2015 Apr 20. pii: jiv239. [Epub ahead of print]

PMID:
25895984
4.

Weighing the risk of drug resistance with the benefits of HIV preexposure prophylaxis.

Grant RM, Liegler T.

J Infect Dis. 2015 Apr 15;211(8):1202-4. doi: 10.1093/infdis/jiu678. Epub 2015 Jan 13. No abstract available.

5.

Transactional sex and prevalence of STIs: a cross-sectional study of MSM and transwomen screened for an HIV prevention trial.

Solomon MM, Nureña CR, Tanur JM, Montoya O, Grant RM, Jeff McConnell J.

Int J STD AIDS. 2014 Dec 17. pii: 0956462414562049. [Epub ahead of print]

PMID:
25520017
6.

Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women.

Grant RM, Liegler T, Defechereux P, Kashuba AD, Taylor D, Abdel-Mohsen M, Deese J, Fransen K, De Baetselier I, Crucitti T, Bentley G, Agingu W, Ahmed K, Damme LV.

AIDS. 2015 Jan 28;29(3):331-7.

PMID:
25503265
7.

The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures.

Ma J, Siminoski K, Alos N, Halton J, Ho J, Lentle B, Matzinger M, Shenouda N, Atkinson S, Barr R, Cabral DA, Couch R, Cummings EA, Fernandez CV, Grant RM, Rodd C, Sbrocchi AM, Scharke M, Rauch F, Ward LM; Canadian STOPP Consortium.

J Clin Endocrinol Metab. 2015 Mar;100(3):1018-27. doi: 10.1210/jc.2014-3096. Epub 2014 Dec 11.

PMID:
25494661
8.

Streamlining HIV testing for HIV preexposure prophylaxis.

Guanira JV, Leigler T, Kallas E, Schechter M, Sharma U, Glidden D, Grant RM; iPrEx Study Team.

J Clin Microbiol. 2015 Jan;53(1):179-83. doi: 10.1128/JCM.01540-14. Epub 2014 Nov 5.

PMID:
25378570
9.

Gay and bisexual men engage in fewer risky sexual behaviors while traveling internationally: a cross-sectional study in San Francisco.

Truong HH, Fatch R, Grasso M, Robertson T, Tao L, Chen YH, Curotto A, McFarland W, Grant RM, Reznick O, Raymond HF, Steward WT.

Sex Transm Infect. 2015 May;91(3):220-5. doi: 10.1136/sextrans-2014-051660. Epub 2014 Oct 29.

PMID:
25355773
10.

Reply to Boyd et al.

Solomon MM, Mayer KH, Glidden DV, Guanira JV, Grant RM.

Clin Infect Dis. 2015 Jan 15;60(2):327. doi: 10.1093/cid/ciu814. Epub 2014 Oct 16. No abstract available.

11.

Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoya O, Buchbinder S, Veloso VG, Mayer K, Chariyalertsak S, Bekker LG, Kallas EG, Schechter M, Guanira J, Bushman L, Burns DN, Rooney JF, Glidden DV; iPrEx study team.

Lancet Infect Dis. 2014 Sep;14(9):820-9. doi: 10.1016/S1473-3099(14)70847-3. Epub 2014 Jul 22.

PMID:
25065857
12.

Regulatory considerations for antiretroviral prophylaxis to prevent HIV acquisition.

Miller V, Grant RM.

Clin Pharmacol Ther. 2014 Aug;96(2):153-5. doi: 10.1038/clpt.2014.114. Review.

PMID:
25056397
13.

HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.

Marrazzo JM, del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH, Montaner JS, Wheeler DP, Grant RM, Grinsztejn B, Kumarasamy N, Shoptaw S, Walensky RP, Dabis F, Sugarman J, Benson CA; International Antiviral Society-USA Panel.

JAMA. 2014 Jul 23-30;312(4):390-409. doi: 10.1001/jama.2014.7999. Erratum in: JAMA. 2014 Jul 23-30;312(4):403. JAMA. 2014 Aug 13;312(6):652.

PMID:
25038358
14.

Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.

Solomon MM, Mayer KH, Glidden DV, Liu AY, McMahan VM, Guanira JV, Chariyalertsak S, Fernandez T, Grant RM; iPrEx Study Team.

Clin Infect Dis. 2014 Oct;59(7):1020-6. doi: 10.1093/cid/ciu450. Epub 2014 Jun 13.

15.

HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.

Liegler T, Abdel-Mohsen M, Bentley LG, Atchison R, Schmidt T, Javier J, Mehrotra M, Eden C, Glidden DV, McMahan V, Anderson PL, Li P, Wong JK, Buchbinder S, Guanira JV, Grant RM; iPrEx Study Team.

J Infect Dis. 2014 Oct 15;210(8):1217-27. doi: 10.1093/infdis/jiu233. Epub 2014 Apr 16.

16.

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.

Marcus JL, Glidden DV, McMahan V, Lama JR, Mayer KH, Liu AY, Montoya-Herrera O, Casapia M, Hoagland B, Grant RM.

PLoS One. 2014 Mar 17;9(3):e91513. doi: 10.1371/journal.pone.0091513. eCollection 2014.

17.

HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.

Buchbinder SP, Glidden DV, Liu AY, McMahan V, Guanira JV, Mayer KH, Goicochea P, Grant RM.

Lancet Infect Dis. 2014 Jun;14(6):468-75. doi: 10.1016/S1473-3099(14)70025-8. Epub 2014 Mar 7.

PMID:
24613084
18.

Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.

Marcus JL, Buisker T, Horvath T, Amico KR, Fuchs JD, Buchbinder SP, Grant RM, Liu AY.

HIV Med. 2014 Aug;15(7):385-95. doi: 10.1111/hiv.12132. Epub 2014 Feb 24. Review.

PMID:
24580813
19.

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.

Solomon MM, Lama JR, Glidden DV, Mulligan K, McMahan V, Liu AY, Guanira JV, Veloso VG, Mayer KH, Chariyalertsak S, Schechter M, Bekker LG, Kallás EG, Burns DN, Grant RM; iPrEx Study Team.

AIDS. 2014 Mar 27;28(6):851-9. doi: 10.1097/QAD.0000000000000156.

20.

Successful use of indwelling tunneled catheters for the management of effusions in children with advanced cancer.

den Hollander BS, Connolly BL, Sung L, Rapoport A, Zwaan CM, Grant RM, Parra D, Temple MJ.

Pediatr Blood Cancer. 2014 Jun;61(6):1007-12. doi: 10.1002/pbc.24902. Epub 2013 Dec 23.

PMID:
24376007
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk